Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
Infection and viral entry of SARS-CoV-2 crucially depends on the binding of its Spike protein to angiotensin converting enzyme 2 (ACE2) presented on host cells. Glycosylation of both proteins is critical for this interaction. Recombinant soluble human ACE2 can neutralize SARS-CoV-2 and is currently...
Prif Awduron: | Tümay Capraz, Nikolaus F Kienzl, Elisabeth Laurent, Jan W Perthold, Esther Föderl-Höbenreich, Clemens Grünwald-Gruber, Daniel Maresch, Vanessa Monteil, Janine Niederhöfer, Gerald Wirnsberger, Ali Mirazimi, Kurt Zatloukal, Lukas Mach, Josef M Penninger, Chris Oostenbrink, Johannes Stadlmann |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
eLife Sciences Publications Ltd
2021-12-01
|
Cyfres: | eLife |
Pynciau: | |
Mynediad Ar-lein: | https://elifesciences.org/articles/73641 |
Eitemau Tebyg
-
Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
gan: Somanath Kallolimath, et al.
Cyhoeddwyd: (2023-06-01) -
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
gan: Riem Gawish, et al.
Cyhoeddwyd: (2022-01-01) -
IgG Glyco-Engineering to Improve IVIg Potency
gan: Christine W. Bruggeman, et al.
Cyhoeddwyd: (2018-10-01) -
Establishment of Reference Interval for M2BPGI Glyco-Biomarker in the Serum of Mongolian People
gan: Uranbaigali Enkhbayar, et al.
Cyhoeddwyd: (2020-12-01) -
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation
gan: Savanna Skeeters, et al.
Cyhoeddwyd: (2024-09-01)